Trump Cut H.I.V. Funding. My Patients Are Scared.news2025-04-08T09:01:36+00:00April 8th, 2025|The New York Times|
For John Green, It’s Tuberculosis All the Way Downnews2025-03-27T14:57:33+00:00March 27th, 2025|The New York Times|
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Ordernews2025-02-07T01:28:34+00:00February 7th, 2025|The New York Times|
Health Programs Shutter Around the World After Trump Pauses Foreign Aidnews2025-02-02T04:18:32+00:00February 2nd, 2025|The New York Times|
Pause on U.S. Funding Spreads Fear of H.I.V. Spike Across Africanews2025-01-30T10:03:19+00:00January 30th, 2025|The New York Times|
Trump Administration Halts H.I.V. Drug Distribution in Poor Countriesnews2025-01-29T07:06:55+00:00January 29th, 2025|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
Gilead Shot Provides Total Protection From HIV in Trial of Young African Womennews2024-06-21T23:30:20+00:00June 21st, 2024|The New York Times|
Los fármacos de acción prolongada podrían revolucionar el tratamiento de VIHnews2024-04-21T07:02:00+00:00April 21st, 2024|The New York Times|
Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatmentnews2024-04-17T22:46:45+00:00April 17th, 2024|The New York Times|
